🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/11/2015 | 58,66 | 62,27 | 58,25 | 61,48 | +4,47% | 6,86% | 623.246 |
| 12/11/2015 | 60,56 | 61,13 | 58,64 | 58,85 | -3,45% | 4,11% | 541.013 |
| 11/11/2015 | 62,20 | 63,94 | 60,75 | 60,95 | -1,41% | 5,12% | 680.313 |
| 10/11/2015 | 56,86 | 64,10 | 56,56 | 61,82 | +3,20% | 13,28% | 1.366.718 |
| 09/11/2015 | 59,86 | 60,25 | 58,30 | 59,91 | +1,88% | 3,26% | 498.693 |
| 06/11/2015 | 59,39 | 59,79 | 57,31 | 58,80 | -0,78% | 4,19% | 354.744 |
| 05/11/2015 | 59,81 | 60,99 | 57,80 | 59,26 | -1,14% | 5,33% | 319.157 |
| 04/11/2015 | 59,11 | 60,86 | 58,25 | 59,95 | +1,62% | 4,42% | 558.004 |
| 03/11/2015 | 58,82 | 60,41 | 57,70 | 59,00 | -0,53% | 4,59% | 402.674 |
| 02/11/2015 | 56,68 | 59,89 | 56,49 | 59,31 | +5,22% | 6,00% | 768.799 |
| 30/10/2015 | 57,01 | 57,77 | 56,18 | 56,36 | -1,20% | 2,80% | 493.564 |
| 29/10/2015 | 57,75 | 58,90 | 56,20 | 57,05 | -0,64% | 4,67% | 498.212 |
| 28/10/2015 | 57,26 | 58,20 | 55,85 | 57,42 | +1,12% | 4,10% | 596.476 |
| 27/10/2015 | 56,43 | 58,01 | 55,90 | 56,78 | +0,47% | 3,75% | 451.084 |
| 26/10/2015 | 55,53 | 57,17 | 54,73 | 56,51 | +1,44% | 4,39% | 378.308 |
| 23/10/2015 | 54,26 | 56,09 | 53,34 | 55,71 | +2,53% | 5,08% | 668.451 |
| 22/10/2015 | 56,06 | 56,21 | 52,99 | 54,34 | -2,17% | 5,73% | 523.219 |
| 21/10/2015 | 54,34 | 56,42 | 52,71 | 55,54 | +3,22% | 6,83% | 666.047 |
| 20/10/2015 | 58,37 | 58,37 | 53,47 | 53,81 | -7,59% | 8,40% | 807.271 |
| 19/10/2015 | 57,83 | 59,63 | 56,44 | 58,22 | +0,27% | 5,51% | 442.749 |
| 16/10/2015 | 59,38 | 60,64 | 57,22 | 58,07 | -2,25% | 5,76% | 467.275 |
| 15/10/2015 | 55,27 | 59,56 | 54,59 | 59,40 | +7,19% | 9,00% | 521.296 |
| 14/10/2015 | 55,02 | 56,65 | 54,32 | 55,41 | +1,87% | 4,23% | 432.489 |
| 13/10/2015 | 55,75 | 57,82 | 54,35 | 54,40 | -3,40% | 6,23% | 351.538 |
| 12/10/2015 | 55,85 | 57,00 | 54,91 | 56,31 | +1,95% | 3,74% | 293.349 |
| 09/10/2015 | 53,90 | 56,15 | 53,21 | 55,23 | +2,45% | 5,45% | 360.354 |
| 08/10/2015 | 54,85 | 56,13 | 52,01 | 53,91 | -2,17% | 7,51% | 478.656 |
| 07/10/2015 | 53,69 | 56,11 | 51,38 | 55,11 | +3,09% | 8,81% | 635.750 |
| 06/10/2015 | 55,07 | 55,61 | 51,02 | 53,46 | -3,98% | 8,33% | 560.569 |
| 05/10/2015 | 56,35 | 57,26 | 53,64 | 55,67 | -0,23% | 6,43% | 398.506 |